My Agentic AI Capital Is Going One Place Over and Over
Every payday the same stock gets another slice of my retirement capital, and three numbers from its latest earnings report make it harder to justify putting that money anywhere else.
My agentic AI dollars keep landing on the same ticker, and I have stopped pretending it will be anything else. Every payday I add a little more Microsoft (NASDAQ:MSFT | MSFT Price Prediction) to the account, and the case for doing it again next month keeps getting stronger.
Microsoft is selling agents into the software my employer already runs, on the cloud my employer already trusts, powered by a model lab it partly owns. That is a distribution advantage no other hyperscaler has assembled in one place, and the receipts show up in every recent earnings report.
Three Numbers That Keep Me Buying
Start with adoption. Microsoft 365 Copilot passed 30 million paid seats in fiscal Q4 2026, and the customer list reads like a directory of the global economy. NHS England is rolling Copilot out to 505,000 clinicians and staff, EY deployed E7 to 400,000 employees, KPMG is expanding across more than 276,000 professionals, and HSBC committed to 200,000 seats. Enterprise deployments to the majority of information workers grew nearly 75% quarter over quarter. Once Copilot is inside Outlook and Teams, ripping it out is a bigger project than adopting it was.
Then the backlog. Commercial remaining performance obligations reached $678 billion, up 84% year over year. Even stripping out the OpenAI relationship, RPO grew 25%, and nearly 90% of full-year Microsoft Cloud revenue came from customers outside frontier model companies. That represents contracted work already sitting on the books. For a retirement-focused portfolio, visibility like that matters.
Third, the cloud engine. Azure crossed $100 billion in annual revenue and grew 43% year over year in Q4, while management guided to approximately 45% constant-currency Azure growth for the next quarter. Beneath it sits an AI business already running at a $37 billion annualized run rate, up 123% year over year. Wrap all of that in a 46.78% operating margin, a 34.04% return on equity, and a 0.29 debt-to-equity ratio, and you have the balance sheet to fund the next leg without borrowing recklessly.
Why Not the Obvious Alternatives
I looked hard at Alphabet (NASDAQ:GOOGL) and Amazon (NASDAQ:AMZN). Both are excellent companies. Microsoft, however, uniquely sits inside the productivity software the Fortune 500 opens every morning. Microsoft’s roughly 27% stake in OpenAI, valued near $135 billion, with IP rights extended through 2032 including post-AGI models, plus OpenAI’s contracted purchase of an incremental $250 billion of Azure services, is a structural arrangement its peers cannot replicate. When agentic AI is billed per outcome as well as per seat, the company holding the model IP, the distribution surface, and the compute contract collects at every layer.
Risk I Am Not Ignoring
Capital spending is the real worry. Full-year fiscal 2026 capex hit $115.95 billion, up 79.62% year over year, and free cash flow fell 6.46% to $66.99 billion. Management has already signaled FY2027 capex will grow again. If AI demand cools, that build becomes an anchor.
What keeps me buying anyway: CFO Amy Hood said the largest slice of that spend is in short-lived CPUs and GPUs that can be slowed if demand shifts, and Microsoft expects to remain free-cash-flow positive in FY2027. Demand today still exceeds available supply.
Forward Conviction
With $678 billion of contracted work, a Copilot install base compounding inside the world’s largest employers, and a model partnership locked through the next decade, Microsoft is where my agentic AI capital keeps going, and I have no plan to stop.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
